ElaC Homolog 2 (ELAC2) (N-Term) Peptid
ELAC2
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5513199
Kurzübersicht für ElaC Homolog 2 (ELAC2) (N-Term) Peptid (ABIN5513199)
Target
ELAC2
(ElaC Homolog 2 (ELAC2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- GRTISQAPAR RERPRKDPLR HLRTREKRGP SGCSGGPNTV YLQVVAAGSR
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- ELAC2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ELAC2 (ElaC Homolog 2 (ELAC2))
-
Hintergrund
-
The protein encoded by this gene has a C-terminal domain with tRNA 3′, processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: ELC2, HPC2, COXPD17
Protein Size: 786 -
Gen-ID
- 60528
-
NCBI Accession
- NM_001165962, NP_001159434
Target
-
Sie sind hier:
